Approvals/TGA/TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe

Approved

STANDARD

TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe

Biogen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 686c8e8a680eb7c2
Product Name: TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe
Artg Id: 353845
Artg Name: TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe
Sponsor: Biogen Australia Pty Ltd
Company Detail Path: /organization/biogen-australia-pty-ltd
Artg Date: 2021-12-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-CMI-01052-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-PI-01015-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

686c8e8a680eb7c2

Type

Standard